<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="general-sciences" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2133</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>General Sciences</subject></subj-group></article-categories><title-group><article-title>SELECTIVE GENE SILENCING BY SMART DELIVERY OF NEWLY DESIGNED RNAI MATERIALS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kitagishi</surname><given-names>Yasuko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yoshida</surname><given-names>Hitomi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Okumura</surname><given-names>Naoko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Murakami</surname><given-names>Mutsumi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nishimura</surname><given-names>Yuri</given-names></name></contrib><contrib contrib-type="author"><name><surname>Matsuda</surname><given-names>Satoru</given-names></name></contrib></contrib-group><volume/><issue/><fpage>101</fpage><lpage>109</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The development of effective therapies for lethal diseases is highly desired. RNA interference (RNAi) is a&#13;
post-transcriptional gene silencing mechanism preserved during evolution. Intriguing aspect of the RNAi&#13;
is its attractive potential therapeutic value, because of their ability to target any disease for which the&#13;
genetic basis is known. As the use of RNAi for gene manipulation-tool has been extensively studied,&#13;
RNAi technology has not only become a powerful tool for functional molecular biology, but also&#13;
represents a promising novel therapeutic option for treating deseases. In this review, we will describe&#13;
these studies that demonstrate the feasibility of using RNAi and discuss potential strategies for improving&#13;
gene silencing. We will also discuss the recent consideration and challenges of using RNAi based&#13;
technologies.&#13;
</p></abstract><kwd-group><kwd>RNA interference</kwd><kwd> gene silencing</kwd><kwd> gene delivery</kwd><kwd> gene therapy</kwd></kwd-group></article-meta></front></article>
